Change in substantial holding
Filed with ASX ·
6ix hasn’t read this filing yet.
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- BREASTESTplus 2 clinically validated
- BCAL Introduces Avantect Multi-Cancer Early Detection Test
- Letter to Shareholders re Annual General Meeting
- Notice of Annual General Meeting/Proxy Form
- Clarification of BCAL's Position in Relation to GSS
Later from BCAL Diagnostics
- Investor Presentation - Transforming Cancer Detection
- Letter to Genetic Signatures Ltd Shareholders
- GSS: Response to Media Speculation & BCAL letter to GSS
- BREASTESTplus Research Presented at Lipidomic Conference
- AGM 2026 Presentation
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics